Covidien

...a serious skin disorder is greater with MRI imaging contrast agents made by GE Healthcare, Bayer AG's <BAYGn. DE> and Covidien <COV.N>, according to an agency memo released on Wednesday. The review recommended that labels for the products...

In this article: FDA, Bayer AG, GE Healthcare, GE, Gadolinium, Magnevist, Nephrogenic systemic fibrosis, and Mallinckrodt Inc.

...Wheeler, Weatherford International, Nabors Industries, Noble Corp., Transocean International, United America Indemnity, Cooper Industries, Covidien, Ingersoll-Rand and Accenture have all completed or taken steps to change their domicile of...

In this article: Barack Obama, Tax, Washington, Accenture, United States, Foster Wheeler, National Assessment of Educational Progress, Ingersoll-Rand, and Cooper Industries

...for Exalgo. " The U.S. rights to Exalgo were acquired from Neuromed by Mallinckrodt Inc., a Covidien company, in June 2009. Under the agreement, Covidien is responsible for all commercialization activities for Exalgo in the U.S.,...

In this article: FDA, Pharmaceutical, United States, Revenue, Mallinckrodt Inc, and Hydromorphone

...got a boost from preparations for the H1N1 virus especially outside the United States, the company said. For fiscal 2010, Covidien said it now expects sales growth of 6 percent to 9 percent from a year ago. It had previously projected...

In this article: New York Stock Exchange, Revenue, Cancer, Actiq, OxyContin, Morgan Stanley, and Tyco International

...FY '10 net sales up 9-12 pct in medical devices * Sees FY 2010 sales flat to up 3 pct in pharmaceuticals Medical products maker Covidien's <COV.N> quarterly earnings topped estimates, helped by the launch of new products, higher volumes...

In this article: Tyco International, Revenue, New York Stock Exchange, and Bangalore

...continuing operations were $0.72Fiscal 2009 diluted GAAP earnings per share from continuing operation DUBLIN - Covidien plc (NYSE: COV) today reported results for the fourth quarter of fiscal 2009 (July - September 2009). Fourth-quarter net...

In this article: Pharmaceutical, Tax, United States, Tyco International, Business operations, and FDA

...Spine Society Annual Meeting in San Francisco and last month at the Congress of Neurological Surgeons in New Orleans. ABOUT COVIDIEN Covidien is a leading global healthcare products company that creates innovative medical solutions for...

In this article: FDA, Surgery, Medical advice, Revenue, Pharmaceutical, Meningitis, and NYSE

...help us achieve our mission of enhancing the quality of life for patients and improving outcomes for our customers. " ABOUT COVIDIEN Covidien is a leading global healthcare products company that creates innovative medical solutions for...

In this article: Revenue, NYSE, Nasdaq, and Dublin

DUBLIN - Covidien (NYSE: COV), a leading global provider of healthcare products, today announced the successful completion of its tender offer through its subsidiary, Transformer Delaware Corp., to purchase all of the outstanding shares of...

In this article: Revenue, NYSE, Nasdaq, and Dublin

...spin-off. The Securities & Exchange Commission investigation and its fallout delayed it, but in June 2007, Tyco Healthcare became Covidien (COV), an independent publicly traded company headquartered in Dublin. (By that time, Tyco had...

In this article: Tyco International, Dennis Kozlowski, Cash flow, Surgery, and BusinessWeek